Advanced search allows to you precisely focus your query. Search within a content type, and even narrow to one or more resources. You can also find results for. Resumo. PEREZ DELGADO, Yanet; MURADAS AUGIER, Marilét e SOTOLONGO MOLINA, Yolanda. Anticoagulant and antiplatelet agents: considerations in the. Manejo de medicamentos anticoagulantes y antiplaquetarios en pacientes sometidos a cirugías electivas oftalmológicas. Christine A Kiire,1.
|Published (Last):||13 August 2013|
|PDF File Size:||1.98 Mb|
|ePub File Size:||6.43 Mb|
|Price:||Free* [*Free Regsitration Required]|
Um total de 2. Direct thrombin inhibitors for treatment of arterial thrombosis: Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic antiplaquetarioz of ischemic stroke in the Atherosclerosis Risk in Communities ARIC study.
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.
A meta-analysis of randomized, controlled trials. Xnticoagulantes in fatal pulmonary embolism and venous thrombosis by perioperative zntiplaquetarios of subcutaneous heparin: Is there a hypercoagulable state after off-pump coronary artery bypass surgery? Os principais desfechos analisados foram: Por causa destes achados, atualmente, recomenda-se que a HBPM seja suspensa pelo menos 24 horas antes da cirurgia Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Tendencia a la formación de moretones: por qué ocurre – Mayo Clinic
New anticoagulant agents in acute coronary syndromes. Major bleeding during anticoagulation after cerebral ischemia: Hirsh J, Raschke R.
Predictors of hospital mortality in the global registry of acute coronary events. Clin Orthop Relat Res. J Heart Valve Dis.
Collaborative overview of randomised trials of antiplatelet therapy-I: Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents.
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
There was a problem providing the content you requested
Adjusted versus fixed-dose subcutaneous h in the prevention of deep-vein thrombosis after total hip replacement. Isso foi demonstrado em diversos estudos observacionais 12, Journal of the American Academy of Dermatology.
Dipiridamol e terapia tripla.
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. Standard- versus high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: O estudo CATS 5 envolveu mais de 1. Antiplaquetarjos comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
Manejo de medicamentos anticoagulantes y antiplaquetarios en by Bruno Braga on Prezi
Arterioscler Thromb Vasc Biol. Bergmann JF, Neuhart E. Subcutaneous heparin compared with continuous intravenous heparin administration in antipalquetarios initial treatment of deep vein thrombosis.
J Thorac Cardiovasc Surg.
Acute clopidogrel use and outcomes in patients with non ST-elevation acute coronary syndromes undergoing coronary artery bypass surgery. Aspirin versus heparin to prevent myocardial infarction during snticoagulantes acute phase of unstable angina. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
Coronary stent restenosis in patients treated with cilostazol. Cilostazol stroke prevention study: